Naratuximab (Anti-TSPAN26 / CD37)

Synonyms: Anti-TSPAN26/CD37 Reference Antibody (naratuximab)

Naratuximab (Anti-TSPAN26 / CD37) is a humanized monoclonal antibody targeting CD37 (TSPAN26). It can be used to synthesize an ADC compound, naratuximab emtansine which is used in treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). MW : 150 KD.

Naratuximab (Anti-TSPAN26 / CD37)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.37mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Naratuximab (Anti-TSPAN26 / CD37) is a humanized monoclonal antibody targeting CD37 (TSPAN26). It can be used to synthesize an ADC compound, naratuximab emtansine which is used in treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). MW : 150 KD.

Product Details

CAS No. 1622327-39-2
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Naratuximab (Anti-TSPAN26 / CD37) | Naratuximab (Anti-TSPAN26 / CD37) supplier | purchase Naratuximab (Anti-TSPAN26 / CD37) | Naratuximab (Anti-TSPAN26 / CD37) cost | Naratuximab (Anti-TSPAN26 / CD37) manufacturer | order Naratuximab (Anti-TSPAN26 / CD37) | Naratuximab (Anti-TSPAN26 / CD37) distributor